{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:08:28Z","timestamp":1769008108780,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Off-label prescribing, the use of medications outside of approved indications, is a common practice in pediatric emergency medicine. This practice is driven by factors such as limited pediatric-specific clinical trial data, regulatory hurdles, and the urgent need to treat critically ill children. While off-label prescribing can be lifesaving, it raises significant ethical and legal concerns. This article explores the prevalence, challenges, and potential consequences of off-label drug use in pediatric emergency departments. A case study illustrates the complexities of off-label prescribing in a real-world clinical scenario. The discussion highlights the importance of balancing clinical needs with regulatory requirements and ethical considerations. Future research should focus on optimizing informed consent procedures, enhancing postmarketing surveillance, and developing evidence-based guidelines to ensure the safe and effective use of off-label medications in pediatric emergency care.<\/jats:p>","DOI":"10.1186\/s13052-025-02176-4","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T09:34:04Z","timestamp":1765618444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond the label: ethical and clinical implications of off-label drug use in pediatric emergency care"],"prefix":"10.1186","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4947-519X","authenticated-orcid":false,"given":"Marco","family":"Colombo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Agosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"issue":"3","key":"2176_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1542\/peds.2013-4060","volume":"133","author":"DA Frattarelli","year":"2014","unstructured":"Frattarelli DA, Galinkin JL, Green TP, et al. Off-label use of drugs in children. Pediatrics. 2014;133(3):563\u20137. https:\/\/doi.org\/10.1542\/peds.2013-4060.","journal-title":"Pediatrics"},{"issue":"5","key":"2176_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3892\/etm.2024.12701","volume":"28","author":"X Yuan","year":"2024","unstructured":"Yuan X, Gao J, Yang L, Tan Y, Bajinka O. Off-label and unapproved pediatric drug utilization: A meta-analysis. Exp Ther Med. 2024;28(5):412. https:\/\/doi.org\/10.3892\/etm.2024.12701.","journal-title":"Exp Ther Med"},{"issue":"6","key":"2176_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12519-018-0186-y","volume":"14","author":"S Balan","year":"2018","unstructured":"Balan S, Hassali MAA, Mak VSL. Two decades of off-label prescribing in children: a literature review. World J Pediatr. 2018;14(6):528\u201340. https:\/\/doi.org\/10.1007\/s12519-018-0186-y.","journal-title":"World J Pediatr"},{"key":"2176_CR4","doi-asserted-by":"publisher","unstructured":"CzarniakP,Bint L, Favi\u00e9 L, Parsons R, Hughes J, Sunderland B. Clinical setting influences off-label and unlicensed prescribing in a pediatric teaching hospital. PLoS ONE. 2015;10(3):e0120630. https:\/\/doi.org\/10.1371\/journal.pone.0120630.","DOI":"10.1371\/journal.pone.0120630"},{"issue":"5","key":"2176_CR5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/1742-6723.12431","volume":"27","author":"D McD Taylor","year":"2015","unstructured":"McD Taylor D, Joffe P, Taylor SE, et al. Off-label and unlicenced medicine administration to pediatric emergency department patients. Emerg Med Australas. 2015;27(5):440\u20136. https:\/\/doi.org\/10.1111\/1742-6723.12431.","journal-title":"Emerg Med Australas"},{"issue":"6","key":"2176_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/children11060735","volume":"11","author":"G Venckute","year":"2024","unstructured":"Venckute G, Zekaite-Vaisniene E, Oniunaite U, Jankauskaite L. Younger children with respiratory tract infections are more exposed to Off-Label treatments: an exploratory retrospective study in a pediatric emergency setting. Children. 2024;11(6):735. https:\/\/doi.org\/10.3390\/children11060735.","journal-title":"Children"},{"key":"2176_CR7","unstructured":"Valletta E, Gangemi M. Off-label drugs in pediatrics: from research to children and back again. 2022 Mar 22 [cited 2024 Oct 23]. Available from: https:\/\/www.farmacovigilanza.eu\/node\/15235 . Accessed 23 oct 2024."},{"key":"2176_CR8","unstructured":"Agenzia Italiana del Farmaco (AIFA). Nuove importanti informazioni di sicurezza su Broncovaleas (salbutamolo). In Italian. Available from: https:\/\/www.aifa.gov.it\/-\/nota-informativa-importante-su-broncovaleas-salbutamolo-27-10-2014 . Accessed 23 oct 2024."},{"key":"2176_CR9","unstructured":"Agenzia Italiana del Farmaco (AIFA). Modifica di indicazioni e popolazione autorizzata dei medicinali a base dell\u2019associazione fissa (FDC) salbutamolo e ipratropio bromuro In Italian. 2023 Jul 5. Available from: https:\/\/www.aifa.gov.it\/-\/modifica-di-indicazioni-e-popolazione-autorizzata-dei-medicinali-a-base-dell-associazione-fissa-fdc . Accessed 23 oct 2024."},{"key":"2176_CR10","doi-asserted-by":"publisher","unstructured":"Indinnimeo L, Chiappini E, Miraglia Del Giudice M, Bernardini R; Italian Panel for the Management of Acute Asthma Attack in Children. Guideline on management of the acute asthma attack in children by the Italian Society of Pediatrics. Ital J Pediatr. 2018;44(1):46. https:\/\/doi.org\/10.1186\/s13052-018-0481-1","DOI":"10.1186\/s13052-018-0481-1"},{"issue":"2","key":"2176_CR11","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.7417\/CT.2018.2059","volume":"169","author":"G Montanari Vergallo","year":"2018","unstructured":"Montanari Vergallo G, Zaami S. Guidelines and best practices: remarks on the Gelli-Bianco law. Clin Ter. 2018;169(2):e82\u201385. https:\/\/doi.org\/10.7417\/CT.2018.2059.","journal-title":"Clin Ter"},{"key":"2176_CR12","unstructured":"Agenzia Italiana del Farmaco (AIFA). Early access and off-label use. https:\/\/www.aifa.gov.it\/en\/accesso-precoce-uso-off-label"},{"issue":"7","key":"2176_CR13","first-page":"576","volume":"14","author":"Zain","year":"2012","unstructured":"Zain, Mithani. Virtual Mentor. 2012;14(7):576\u201381.","journal-title":"Virtual Mentor"},{"key":"2176_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11096-021-01303-5","volume":"44","author":"B Guidi","year":"2022","unstructured":"Guidi B, Parziale A, Nocco L, et al. Regulating pediatric of-label uses of medicines in the EU and USA: challenges and potential solutions. Int J Clin Pharm. 2022;44:264\u20139. https:\/\/doi.org\/10.1007\/s11096-021-01303-5.","journal-title":"Int J Clin Pharm"},{"key":"2176_CR15","unstructured":"EUSEM Ethics Committee. Recommendations on informed consent for European emergency departments for adults and children. https:\/\/eusem.org\/images\/Patient_Informed_Consent_in_the_ED-FINAL.pdf . Accessed 23 oct 2024."},{"issue":"6","key":"2176_CR16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1046\/j.1365-2125.2002.t01-3-01689.x","volume":"54","author":"B Horen","year":"2002","unstructured":"Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in pediatric outpatients. Br J Clin Pharmacol. 2002;54(6):665\u201370. https:\/\/doi.org\/10.1046\/j.1365-2125.2002.t01-3-01689.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2176_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/1574886313666180619120406","volume":"13","author":"AD Pratico","year":"2018","unstructured":"Pratico AD, Longo L, Mansueto S, et al. Off-Label use of drugs and adverse drug reactions in pediatric units: A Prospective, multicenter study. Curr Drug Saf. 2018;13(3):200\u20137. https:\/\/doi.org\/10.2174\/1574886313666180619120406.","journal-title":"Curr Drug Saf"},{"key":"2176_CR18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12887-022-03457-1","volume":"22","author":"M Meng","year":"2022","unstructured":"Meng M, Liu E, Zhang B, et al. Guideline for the management of pediatric off-label use of drugs in China (2021). BMC Pediatr. 2022;22:442. https:\/\/doi.org\/10.1186\/s12887-022-03457-1.","journal-title":"BMC Pediatr"},{"issue":"8","key":"2176_CR19","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.21037\/tp-24-198","volume":"13","author":"M Meng","year":"2024","unstructured":"Meng M, Hu J, Lei W, et al. The implementation of the guideline for the management of pediatric off-label use of drugs in china: a cross-sectional study. Transl Pediatr. 2024;13(8):1425\u201338. https:\/\/doi.org\/10.21037\/tp-24-198.","journal-title":"Transl Pediatr"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02176-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-02176-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02176-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:02:52Z","timestamp":1768953772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13052-025-02176-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2176"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-02176-4","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication has been obtained from the patients\u2019 parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}